KYORIN Pharmaceutical Market Cap

KYORIN Pharmaceutical has a market cap or net worth of 93.99 billion as of March 9, 2026. Its market cap has increased by 18.21% in one year.

Market Cap

93.99B

Enterprise Value

105.57B

Revenue

133.26B

Ranking

n/a

PE Ratio

8.73

Stock Price

1,636.00

Market Cap Chart

Since March 10, 2006, KYORIN Pharmaceutical's market cap has increased from 18.24B to 93.99B, an increase of 415.18%. That is a compound annual growth rate of 8.54%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	93.99B	6.44%
Dec 30, 2025	88.30B	2.13%
Dec 30, 2024	86.46B	-15.45%
Dec 29, 2023	102.26B	3.75%
Dec 30, 2022	98.56B	-6.82%
Dec 30, 2021	105.78B	-4.89%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Zeria Pharmaceutical	95.21B
Mochida Pharmaceutical	130.81B
ASKA Pharmaceutical Holdings	66.08B
Fuji Pharma	57.41B
Kaken Pharmaceutical	162.27B
Kissei Pharmaceutical	191.09B
Towa Pharmaceutical	206.76B
Daito Pharmaceutical	43.57B

Market Cap Rankings